New real-world data from ASRS 2026 show nearly 40% of wet AMD patients go 180+ days without anti-VEGF treatment within a year ...
Retina World Congress 2026 recap: Durability, diagnosis, discovery, and what’s next in retina care
Presenters highlight clinical insights and lessons from recent trial data and surgical experience On efficacy, Regillo said ...
REMAIN data show MCO-010 optogenetic therapy delivered durable ~3-line vision gains in retinitis pigmentosa regardless of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results